(as of January 1, 2023)
PREFACE
These texts are English translation of the Japanese “Matters to be Instructed by Veterinary Officers,” but not the official translation.
These translations should be used solely as reference material to aid in understanding of the original Japanese texts.
Only the original Japanese texts of “Matters to be Instructed by Veterinary Officers” are official and have effect, and in event of any doubt as to the interpretation of these texts, it is advised that reference should be made to the original Japanese text.
The JRA shall not be responsible for any losses, damages and troubles caused by mistranslations and/or interpretations that differ from the actual facts.
TABLE OF CONTENTS
Regulation of Administration of Drugs and Medication to RacehorsesVeterinary Practitioners and Visiting Veterinarians
Saddling Enclosure
Sample Collecting Enclosure
(Notice from the President of the Japan Racing Association / No. 13, March 23rd, 2022)
Matters to be Instructed by Veterinary Officers Concerning the Regulation of Drug and Medication Administration and Prohibited Practices with Respect to Racehorses
Table of Contents
Chapter 1 General Provisions (Article 1 to Article 7)
Chapter 2 Use of Drugs and Medication (Article 8 to Article 14)
Chapter 3 Prohibited Practices, etc. (Article 15 and Article 16)
Chapter 4 Out of Competition Testing (Article 17)
Chapter 5 Miscellaneous Provisions (Article 18)
Supplementary Provision
Chapter 1 General Provisions
( Purpose )
Art. 1 The purpose of these regulations shall be to prescribe matters required as instructions from veterinary officers to stable personnel (trainers, jockeys, trainee jockeys, assistant trainers, and grooms. Hereinafter the same shall apply) in connection with the regulation of the administration of drugs or medication to racehorses and prohibited practices (activities whose conduct with respect to horses is restricted from the standpoint of ensuring the fairness of racing, the welfare of horses. and the prevention of accidents during the race. Hereinafter the same shall apply) based on Article 90-2 and Article 132-3 of the JRA Rules of Racing (President's Notice No. 28, 2007. Hereinafter “Rules of Racing”).
( Management of Stables )
Art. 2 To ensure the integrity of racing, trainers shall pay particular attention to the rearing management of racehorses, and must not indiscriminately allow anyone other than related personnel to enter stables managed by themselves.
( Instructions to Stable Personnel )
Art. 3 Trainers must pay particular attention to the management of horses that are scheduled to run in races within the following 10 days (hereinafter “scheduled runners”), and must give necessary instructions to stable employees and other personnel who handle said horses (jockeys, trainee jockeys, assistant trainers and stable employees. Hereinafter the same shall apply).
( Requests for Treatment )
Art. 4 Stable personnel must, when treatment is required for racehorses managed or handled by themselves, request treatment from a JRA veterinarian, veterinary practitioner (a veterinarian who leases facilities to provide medical service to JRA racehorses based on the Standards for Lease of JRA Racehorse Examination and Farriery Facilities [President's Notice No. 25, 1979]. Hereinafter the same shall apply) or a visiting veterinarian (a veterinarian who has obtained approval to provide medical service to racehorses inside JRA facilities based on the Regulations for Prevention of Infectious Diseases among JRA Racehorses [President's Notice No. 11, 1955. Hereinafter the same shall apply). In such cases, when stable employees or other personnel wish to request treatment, they must first obtain the permission of the relevant trainer.
( Attendance at Treatment )
Art.5 When a racehorse managed or handled by stable personnel is to undergo treatment, said personnel must notify the JRA veterinarian, veterinary practitioner, or visiting veterinarian (hereinafter “JRA veterinarian, etc.”) of the said horse's running schedule, and must also attend said examination.
( Entry Examination )
Art. 6 When intending to enter a racehorse managed by themselves that has been designated by JRA in a race, trainers must have the horse examined by a JRA veterinarian before making a declaration to start the horse in the race.
2. When a veterinary officer gives instructions concerning measures to be taken for said racehorse based on the results of the examination set forth in the preceding Paragraph, the trainer must comply with those instructions.
( Treatment From the Day Before a Race )
Art. 7 Stable personnel may not have a horse treated in the period from the day before a race in which the horse is scheduled to run until said race has finished (or, for horses falling under the category of horses prescribed in Paragraph 1 of Article 134 of the Rules of Racing, until the signature prescribed in Paragraph 7 of the same Article is completed). In such cases, if emergency treatment is required owing to illness or injury, the stable personnel must immediately notify a veterinary officer or a JRA veterinarian designated by a veterinary officer (hereinafter “veterinary officer, etc.”) to that effect, and must follow the instructions thereof.
Chapter 2 Use of Drugs and Medication
( Management of Drugs and Medication )
Art. 8 When a JRA veterinarian, etc., has administered a prohibited drug (drug or medicine that temporarily increases or decreases the horse’s ability to compete that is set forth in Separate Table (1). Hereinafter the same shall apply) or a restricted drug (drug or medicine whose administration is restricted in view of the welfare of horses and the prevention of accidents during the race, and which is set forth in Separate Table (2). Hereinafter the same shall apply) to a horse that is managed by themselves, trainers must receive and approve a report pertaining to the name of the administered drug from said veterinarian and also keep records pertaining to the treatment received by the horse and submit those records when requested by a veterinary officer, etc.
( Compliance with regard to Prohibited Drugs, etc )
Art. 9 When a prohibited drug has been used for a racehorse managed by themselves, trainers may not make a declaration to start in any race held within 10 days counting from the date on which said substance was last used (or, when a prohibited drug set forth in No. 40 or 80 of Separate Table (1) has been used, within 5 days counting from the date on which said substance was used).
2. When a scheduled runner falls under any of the following Items, stable personnel must immediately notify a veterinary officer, etc., to that effect, and must follow the instructions thereof.
- （1）When it is deemed that a prohibited drug or medication has been used or could have been used.
- （2）When it is deemed that a drug or medication other than a prohibited drug has been used or could have been used for purposes of temporarily raising or lowering the race performance of the horse.
- （3）When an abnormal condition that is other those prescribed in the preceding two Items has been discovered.
Art. 10 When a restricted drug has been used for a racehorse managed by themselves, trainers may not make a declaration to start the horse while it is under the influence thereof or allow the horse to run in any race held while it is under the influence thereof.
2. When a restricted drug has been used for a racehorse managed by themselves, trainers may not make a declaration to start the horse within the Restriction Period or allow the horse to run in any race held within the Restriction Period. (i.e. a period of time during which a horse is restricted from running as a period during which it is deemed inappropriate to run in a race if the restricted drugs are used. Hereinafter the same shall apply)
3. The Restriction Period in the preceding paragraph is set forth in Separate Table (3).
4. When they deem that a racehorse managed or handled by themselves could run in a race that will be held within Restriction Period or while the horse is under the influence of a restricted drug, stable personnel must immediately notify a veterinary officer, etc., to that effect and follow the instructions thereof.
Art. 11 When planning to stable a racehorse in a JRA (training) facility, trainers must confirm whether or not anabolic steroids (those prescribed in the Remarks to Separate Table (1). Hereinafter the same shall apply) have been used for said horse.
2. Trainers must give necessary instructions to personnel involved with a racehorse managed by themselves and take other appropriate measures to ensure that anabolic steroids are not used for said horse, regardless of whether inside or outside a JRA facility.
3. Stable personnel must, when they deem that anabolic steroids have been used or could have been used for a racehorse managed or handled by themselves, regardless of whether inside or outside a JRA facility, immediately notify a veterinary officer, etc., to that effect and follow the instructions thereof.
4. When it has been confirmed that anabolic steroids are present in a racehorse managed by themselves through the testing prescribed in Item 1, Paragraph 1 of Article 17, or when it is otherwise discovered that said horse is under the influence of anabolic steroids, notwithstanding the provisions of Paragraph 1 of Article 9, trainers must not make a declaration to start said horse unless the absence of those anabolic steroids has been confirmed in the testing prescribed in Item 1, Paragraph 1 of Article 17 to be conducted after six months have elapsed from the date of said confirmation or discovery.
( Restrictions on the Use of Equipment and Substances for Treatment )
Art. 12 Stable personnel may not use or place inside stables any treatment equipment, prohibited drugs, restricted drugs, or delivered drugs (substances not obtained through prescription from a JRA veterinarian, etc.); provided, however, that this shall not apply to items that JRA specially approves.
( Health Management Products )
Art. 13 Health Management Products (wet compresses, disinfectants and others used in the daily management of racehorses) that may be used by stable personnel shall be limited to those that have been tested by the Laboratory of Racing Chemistry and that have been prescribed by a JRA veterinarian, etc., or purchased from a person approved by the President.
( Feed )
Art. 14 Feed that may be provided to racehorses by stable personnel at JRA facilities is limited to feed that is in conformity with the Implementation Procedures Pertaining to Feed Drug Testing set forth by the Feed Drug Testing Supervisory Committee prescribed in the Notice on Feed Given to Racehorses (President's Notice No. 11, 2019) and delivered to stables by persons authorized by the President; provided, however, that, in cases where a horse is to receive racehorse registration for an international exchange race as provided in Article 57-1 of the Enforcement Regulations of the Horse Racing Law (Ordinance of the Ministry of Agriculture and Forestry No. 55 of 1954), feed may be given to said horse upon being approved by a veterinary officer when said horse is to be tested for prohibited drugs and restricted drugs prior to the declaration to start in that race as separately determined by the veterinary officer.
Chapter 3 Prohibited Practices, etc.
( Prohibited Practices )
Art. 15 Trainers must not engage in the Prohibited Practices set forth in the following Items with respect to a racehorse managed by themselves.
- （1）Running a horse aged 4 years or older in a race to be conducted within one month from the date of administration of a bisphosphonate or other bone resorption inhibitors
- （2）Running a horse in a race to be conducted within 10 days from the date of administration of a polyacrylamide gel or glucocorticoid intra-articular administration
- （3）Running a horse in a race to be held within 7 days from the date of conducting shockwave therapy (a treatment involving the application of shockwaves to an affected part of the body) on a lower limb
- （4）Running a horse in a race to be held within one month from the date of administration of ozone or ozone-treated substances
2. Trainers must keep records on treatments received by a racehorse managed by themselves and take other appropriate measures to ensure that the prohibited methods set forth in the following Items are not taken for said horse, regardless of whether inside or outside a JRA facility.
- （1）Administering blood, blood products, or blood cells to any cardiovascular system other than for life-saving treatment
- （2）Administering genes and related substances
- （3）Performing chemical or immunological castration
- （4）Performing a neurectomy to intentionally eliminate pain sensation
- （5）Performing bloodletting (draining blood to outside the body) or scarification (inserting needles into the horse’s skin to drain accumulated blood)
- （6）Performing treatment using cauterization (promoting healing of an inflamed area by stimulating it with heat to cause new inflammation)
- （7）Applying substances that cause blistering of skin or subcutaneous cells
- （8）Administering bisphosphonates or other bone resorption inhibitors to horses under 4 years of age
3. Stable personnel must, when they deem that a prohibited practices prescribed in the previous Items was performed or could have been performed for a racehorse managed or handled by themselves, regardless of whether inside or outside a JRA facility, immediately notify a veterinary officer, etc., to that effect and follow the instructions thereof.
( Prohibition of Quasi-Veterinary Practice )
Art. 16 Stable personnel may not allow a person who is not a JRA veterinarian, etc., to carry out examination, drug administration, or other quasi-veterinary practice nor undertake such acts themselves.
2. Stable personnel may carry out first aid and health care acts (treatment of mild injuries, use of micro-radar, and other acts for the purpose of maintaining the health of horses) under instruction from a JRA veterinarian, etc.
Chapter 4 Out of Competition Testing
( Out of Competition Testing )
Art. 17 Trainers must have a racehorse managed by themselves that has been designated by JRA undergo the testing prescribed in the following Items.
- （1）Testing for anabolic steroids
- （2）Other testing in addition to that prescribed in the previous Item that a veterinary officer deems to be necessary
2. The trainer of a horse that is the subject of the testing prescribed in the preceding Paragraph must appear at a place designated by JRA and observe the collection of testing materials from said horse as a witness to the testing. In this case, the trainer of said horse may have a person authorized by JRA fulfill this duty.
Chapter 5 Miscellaneous Provisions
( Other Matters )
Art. 18 Besides those prescribed in this Notice, any matters required as instructions to stable personnel concerning regulation of drug and medication administration and Prohibited Practices with respect to racehorses shall be determined by a veterinary officer.
Supplementary Provision
This Notice shall take effect from April 1st, 2022.
Supplementary Provision
(Notice from the President of the Japan Racing Association/No.31; November 25th, 2022)
This Notice shall take effect from January 1st, 2023. However, the revised provisions of Article 9-1, Separate Table (1) and Separate Table (2) shall come into force as from 1 April 2024.
Separate Table (1) (Related to Article 8, Article 9, and Article 11)
|
|
Remarks: Quinbolone, Stanozolol, Testosterone, Trenbolone, Nandrolone, Furazabol, Fluoxymesterone, Boldione, Boldenone, 17α-methylsteroids, and Methenolone, as well as any other substances that contain or extricate any one of these substances, shall be known collectively as “anabolic steroids.”
Separate Table (2) (Related to Article 8 and Article 10)
- 1.Glucocorticosteroids (Cortisone, Dexamethasone, Triamcinolone, Triamcinolone Acetonide, Hydrocortisone, Fludrocortisone, Prednisolone, Betamethasone, Methylprednisolone, and other substances with similar chemical structure or similar biological effect(s))
- 2.Non-Steroidal Anti-Inflammatory Drugs (Aspirin, Acetaminophen, Acemetacin, Aminopyrine, Antipyrine, Ampiroxicam, Amfenac, Isopropylantipyrine, Ibuprofen, Indometacin, Ethenzamide, Etodolac, Etoricoxib, Epirizole, Emorfazone, Eltenac, Oxaprozin, Oxyphenbutazone, Carprofen, Glycyrrhizinate, Ketophenylbutazone, Ketoprofen, Ketorolac, Salicylamide, Sodium Salicylate, Methyl Salicylate, Zaltoprofen, Diclofenac, Dimetotiazine, Sulindac, Sulpyrine, Celecoxib, Tiaprofenic acid, Tiaramide, Tenoxicam, Tepoxalin, Deracoxib, Tolfenamic acid, Nabumetone, Naproxen, Valdecoxib, Piroxicam, Firocoxib, Phenacetin, Phenylbutazone, Felbinac, Bucolome, Pranoprofen, Flunixin, Flufenamic acid, Flurbiprofen, Proglumetacin, Vedaprofen, Meclofenamic acid, Mefenamic acid, Meloxicam, Mofezolac, Loxoprofen, Lornoxicam, Neurotropin, and other substances with similar chemical structure or similar biological effect(s))
- 3.Anti-Allergy Agents (Cyproheptadine and Methapyrilene)
- 4.Bronchodilator Agents (Ipratropium, Oxyethyltheophylline, Oxypropyltheophylline, Dihydroxypropyltheophylline, and Noscapin)
- 5.Gastroprokinetic Agents (Atropine and Scopolamine)
- 6.Local Anesthetics (Dibucaine, Tetracaine, Procaine, and Lidocaine)
- 7.Diuretics (Furosemide)
- 8.Skeletal Muscle Relaxants (Guaifenesin and Methocarbamol)
Separate Table (3) (Related to Article 10).
| Restricted Drugs | Race Restriction Period (Days) |
Dosage and administration on the basis of which the period is set |
|---|---|---|
| Atropine | 3 | 1 milligram (mg) of atropine sulphate per horse four times a day by eye drops |
| Indomethacin | 3 | 500 mg per animal, applied once daily for 3 days |
| Eltenac | 14 | 0.5 mg per kilogram (kg) of body by weight intravenous adm. once daily for 5 days |
| Carprofen | 15 | 0.7 mg per kg of body weight by intravenous adm. |
| Ketoprofen | 5 | 2.2 mg per kg of body weight by intravenous adm. once daily for 5 days |
| 10 | 2.2 mg per kg body weight by intramuscular adm. | |
| Diclofenac | 5 | 1 mg of diclofenac sodium per kg body weight by oral adm. once daily for 3 days |
| Dexamethasone | 5 | 0.06 mg as dexamethasone sodium phosphate per kg body weight by intravenous adm. |
| 8 | 0.05 mg per kg body weight by intramuscular adm. | |
| Naproxen | 30 | 10 mg per kg body weight by oral adm. once daily for 5 days |
| Filocoxib | 30 | 0.1 mg per kg body weight by oral adm. once daily for 5 days |
| Phenylbutazone | 10 | 8.8 mg per kg body weight by intravenous adm. |
| 10 | 4.7 mg per kg body weight by oral adm. twice daily for 5 days | |
| Flunixin | 7 | 1.1 mg per kg body weight by intravenous adm. |
| Prednisolone | 3 | 1 mg per kg body weight by oral adm. |
| Procaine | 15 | 4.8 mg per kg body weight by intramuscular adm. |
| Betamethasone | 5 | 0.06 mg per kg body weight by intravenous adm. |
| 6 | 20 mg per horse by intramuscular adm. | |
| 5 | Inhalation 4 mg per horse once daily for 5 days | |
| Meloxicam | 4 | 0.6 mg per kg body weight by intravenous adm. |
| 4 | 0.6 mg per kg body weight by oral adm. once daily for 14 days | |
| Lidocaine | 5 | 60 mg of lidocaine hydrochloride per head by subcutaneous adm. |
(Remark.)
1 The number of days of the restricted period shall be calculated from the date of use of the relevant restricted drugs.
2 The restricted period for restricted drugs not specified in this table and the restricted period for the use of restricted drugs listed in the left-hand column of the table other than in the dosage and administration listed in the right-hand column of the table shall be as directed by the Veterinary Officer.
(Notice from the President of the Japan Racing Association / No. 35, September 3, 2007)
Matters to be Instructed by Veterinary Officers to Veterinary Practitioners and Visiting Veterinarians
( Purpose )
Art. 1 The purpose of these regulations shall be to prescribe matters required as instructions from veterinary officers in connection with treatment and prohibited practices(activities whose conduct with respect to horses is restricted from the standpoint of ensuring the fairness of racing, the welfare of horses. and the prevention of accidents. Hereinafter the same shall apply) to veterinary practitioners (veterinarians who lease facilities to provide medical service to JRA racehorses based on the Standards for Lease of JRA Racehorse Examination and Farriery Facilities [President's Notice No. 25, 1979; hereinafter “Standards for Lease”] Hereinafter the same shall apply) and visiting veterinarians (veterinarians who have obtained approval to provide medical service to racehorses inside JRA facilities based on the Regulations for Prevention of Infectious Diseases among JRA Racehorses [President's Notice No. 11, 1955 hereinafter “Prevention Regulations”] Hereinafter the same shall apply).
( Management of Equipment )
Art. 2 Veterinary practitioners and visiting veterinarians (hereinafter “veterinary practitioner, etc.”) must strictly manage treatment equipment, drugs, and supplements (products to assist in the intake of vitamins and other nutrients. Hereinafter the same shall apply).
Art. 3 A veterinary practitioner, etc., must not place treatment equipment, drugs, and supplements in any location other than the facility for the treatment of JRA racehorses that he/she leases and the vehicle he/she uses to make treatment visits.
( Attendance at Treatment )
Art. 4 When requested to provide treatment for a racehorse from a stable staff members (trainers, jockeys, trainee jockeys, assistant trainers, or grooms. Hereinafter the same shall apply), a veterinary practitioner, etc., must confirm the races that the horse is scheduled to run with said stable staff member and provide treatment in the presence of said stable staff member.
( Drugs having Prohibited or Restricted Use )
Art. 5 A veterinary practitioner, etc., must not use anabolic steroids (those prescribed in the Remarks to Separate Table (1). Hereinafter the same shall apply) on a racehorse.
2. A veterinary practitioner, etc., must be aware that if he/she administers to a racehorse a prohibited drug other than anabolic steroids (drug or medicine that temporarily increases or decreases the horse’s ability to compete that is set forth in Separate Table (1). Hereinafter the same shall apply), a declaration to start for said horse may not be made for any race held within 10 days counting from the date on which said drug was last used (or, when a prohibited drug set forth in No. 40 or 80 of Separate Table (1) has been used, within 5 days counting from the date on which said drug was used).
3. A veterinary practitioner, etc., must be aware that if he/she administers to a racehorse a restricted drug (drug or medicine whose administration is restricted in view of the welfare of horses and the prevention of injuries, and which is set forth in Separate Table (2). Hereinafter the same shall apply), said horse will not be permitted to have a declaration to start made for it while it is under the influence of the restricted drug or to run in any race held while it is under the influence of the restricted drug.
4. A veterinary practitioner, etc., must be aware that said horse will not be permitted to have a declaration to start made for it within the Restriction Period or allow the horse to run in any race held within the Restriction Period. (i.e. a period of time during which a horse is restricted from running as a period during which it is deemed inappropriate to run in a race if the restricted drugs are used. Hereinafter the same shall apply)
5. The Restriction Period in the preceding paragraph is set forth in Separate Table (3).
6. When a veterinary practitioner, etc., has administered a prohibited drug other than anabolic steroids or restricted drug to a racehorse, he/she must provide appropriate guidance to the stable personnel who manage or handle said horse.
( Pre-race examinations of racehorses )
Art. 6 If a veterinary practitioner, etc., discovers an abnormality in a horse that is scheduled to run a race within the following 10 days, he/she must immediately notify a veterinary officer or a JRA veterinarian designated by a veterinary officer (hereinafter “veterinary officer, etc.”) to that effect, and must follow the instructions thereof.
Art. 7 Veterinary practitioners must not treat a horse in the period from the day before a race in which the horse is scheduled to run until said race has finished (or, for horses falling under the category of horses prescribed in Paragraph 1 of Article 134 of the JRA Rules of Racing, until the signature prescribed in Paragraph 7 of the same Article is completed). In such cases, if emergency treatment is required owing to illness or injury, veterinary practitioners must immediately notify a veterinary officer, etc., to that effect, and must follow the instructions thereof.
( Administration of Drugs )
Art. 8 When a veterinary practitioner, etc., will administer a prohibited drug other than anabolic steroids or restricted drug to a horse, he/she must administer the drug him/herself.
2. When a veterinary practitioner, etc., has administered a drug as prescribed in the previous Paragraph, he/she must report immediately the name of the drug used and the horse’s name to the horse’s trainer and a JRA veterinarian.
( Drugs and Medication That May Be Possessed )
Art. 9 The drugs, supplements, and health management products(wet compresses, disinfectants, and others used in the daily management of racehorses) that may be possessed or used by a veterinary practitioner, etc., shall be limited to those that have been tested by the Laboratory of Racing Chemistry and reported in advance to JRA.
( Prohibited Practices )
Art. 9-2 A veterinary practitioner, etc., must not engage in the prohibited practices set forth in the following Items with respect to a racehorse, regardless of whether inside or outside a JRA facility.
- （1）Administering blood, blood products, or blood cells to any cardiovascular system other than for life-saving treatment
- （2）Administering genes and related substances
- （3）Performing chemical or immunological castration
- （4）Performing a neurectomy to intentionally eliminate pain sensation
- （5）Performing bloodletting (draining blood to outside the body) or scarification (inserting needles into the horse’s skin to drain accumulated blood)
- （6）Performing treatment using cauterization (promoting healing of an inflamed area by stimulating it with heat to cause new inflammation)
- （7）Applying substances that cause blistering of skin or subcutaneous cells
- （8）Administering bisphosphonates or other bone resorption inhibitors to a horse under 4 years of age
- （9）Administering bisphosphonates or other bone resorption inhibitors to a horse 4 years of age or older that is scheduled to run a race within the following one month
- （10）Administering a polyacrylamide gel or glucocorticoid intra-articularly to a horse that is scheduled to run in a race within the following ten days
- （11）Conducting shockwave therapy (a treatment involving the application of shockwaves to an affected part of the body) on a lower limb of a horse that is scheduled to run in a race within the following 7 days
- （12）Administering ozone or ozone-treated substances on a horse that is scheduled run a race within the following one month
( Submission of Daily Treatment Reports )
Art. 10 Whenever a veterinary practitioner, etc., has provided treatment, he/she must submit a daily treatment report to a JRA veterinarian as soon as possible using a format to be determined by a veterinary officer.
( Cancellation of Approval )
Art. 11 If a veterinary practitioner violates any of the provisions of these Regulations, JRA may cancel his/her approval to lease JRA facilities to provide medical service based on the Standards for Lease.
2. Art. 11 If a visiting veterinarian violates any of the provisions of these Regulations, JRA may cancel his/her approval to provide medical treatment for racehorses within JRA facilities based on the “Prevention Regulations.”
( Other Matters )
Art. 12 Besides those prescribed in these Regulations, any matters required as instructions to veterinary practitioners, etc., shall be determined by a veterinary officer.
Supplementary Provision
This Notice shall take effect from October 1st, 2007.
Supplementary Provision (Notice from the President of the Japan Racing Association / No. 33, September 25th, 2009)
This Notice shall take effect from November 11th, 2009.
Supplementary Provision (Notice from the President of the Japan Racing Association / No. 39, June 22nd, 2011)
This Notice shall take effect from June 22nd, 2011, and the provisions of the revised Matters to be Instructed by Veterinary Officers to Veterinary Practitioners and Visiting Veterinarians shall apply from June 1st of the same year.
Supplementary Provision (Notice from the President of the Japan Racing Association / No. 47, August 25th, 2011)
This Notice shall take effect from October 1st, 2011.
Supplementary Provision (Notice from the President of the Japan Racing Association / No. 10, February 25th, 2013)
This Notice shall take effect from April 1st, 2013. However, the revised provision adding Adrafinil, Aminophylline, Aminorex, Alprenoxime, Amphetaminil, Ibuterol, Ethylamphetamine, Ethylmorphine, Carbamazepine, Quinbolone, Guaifenesin, Clobenzorex, Codeine, Choline Theophylline, Cyclazodone, Dimethylamphetamine, Selegiline, Dextroamphetamine, Testosterone, Deprenyl, Tramadol, Bambuterol, Famprofazone, Fenethylline, Fencamine, Fenproporex, Furfenorex, Prenylamine, Betaxolol, Heroin, Benzphetamine, Ketazolam, Demoxepam, Nordazepam, Halazepam, Pinazepam, Fosazepam, Boldione, Mesocarb, Methocarbamol, Mefenorex, Modafinil, and Lisdexamfetamine in the revised provision of Separate Table (1) and the revised provision adding Quinbolone, Testosterone, and Boldione in the revised provision of the Remarks to the same table shall come into effect on April 1, 2014.
Supplementary Provision (Notice from the President of the Japan Racing Association / No. 40, February 25th, 2014)
This Notice shall take effect from April 1st, 2015.
Supplementary Provision (Notice from the President of the Japan Racing Association / No. 9, March 31, 2016)
This Notice shall take effect from April 1st, 2016.
Supplementary Provision (Notice from the President of the Japan Racing Association / No. 13; September 25th, 2019)
This Notice shall take effect from January 1st, 2020.
Supplementary Provision (Notice from the President of the Japan Racing Association / No. 5; January 26, 2022)
This Notice shall take effect from February 1st, 2022.
Supplementary Provision (Notice from the President of the Japan Racing Association / No. 14; March 23rd, 2022)
This Notice shall take effect from April 1st, 2022.
Supplementary Provision (Notice from the President of the Japan Racing Association / No. 30; November 25th, 2022)
This Notice shall take effect from January 1st, 2023. However, the revised provisions of Article 5-2, Separate Table (1) and Separate Table (2) shall come into force as from 1 April 2024.
Separate Table (1) (Related to Article 5 and Article 8)
|
|
Remarks: Quinbolone, Stanozolol, Testosterone, Trenbolone, Nandrolone, Furazabol, Fluoxymesterone, Boldione, Boldenone, 17α-methylsteroids, and Methenolone, as well as any other substances that contain or extricate any one of these substances, shall be known collectively as “anabolic steroids.”
Separate Table (2) (Related to Article 5 and Article 8)
- 1.Glucocorticosteroids (Cortisone, Dexamethasone, Triamcinolone, Triamcinolone Acetonide, Hydrocortisone, Fludrocortisone, Prednisolone, Betamethasone, Methylprednisolone, and other substances with similar chemical structure or similar biological effect(s) )
- 2.Non-Steroidal Anti-Inflammatory Drugs (Aspirin, Acetaminophen, Acemetacin, Aminopyrine, Antipyrine, Ampiroxicam, Amfenac, Isopropylantipyrine, Ibuprofen, Indometacin, Ethenzamide, Etodolac, Etoricoxib, Epirizole, Emorfazone, Eltenac, Oxaprozin, Oxyphenbutazone, Carprofen, Glycyrrhizinate, Ketophenylbutazone, Ketoprofen, Ketorolac, Salicylamide, Sodium Salicylate, Methyl Salicylate, Zaltoprofen, Diclofenac, Dimetotiazine, Sulindac, Sulpyrine, Celecoxib, Tiaprofenic acid, Tiaramide, Tenoxicam, Tepoxalin, Deracoxib, Tolfenamic acid, Nabumetone, Naproxen, Valdecoxib, Piroxicam, Firocoxib, Phenacetin, Phenylbutazone, Felbinac, Bucolome, Pranoprofen, Flunixin, Flufenamic acid, Flurbiprofen, Proglumetacin, Vedaprofen, Meclofenamic acid, Mefenamic acid, Meloxicam, Mofezolac, Loxoprofen, Lornoxicam, Neurotropin, and other substances with similar chemical structure or similar biological effect(s))
- 3.Anti-Allergy Agents (Cyproheptadine and Methapyrilene)
- 4.Bronchodilator Agents (Ipratropium, Oxyethyltheophylline, Oxypropyltheophylline, Dihydroxypropyltheophylline, and Noscapin)
- 5.Gastroprokinetic agents (Atropine and Scopolamine)
- 6.Local Anesthetics (Dibucaine, Tetracaine, Procaine, and Lidocaine)
- 7.Diuretics (Furosemide)
- 8.Skeletal Muscle Relaxants (Guaifenesin and Methocarbamol)
Separate Table (3) (Related to Article 10).
| Restricted Drugs | Race Restriction Period (Days) |
Dosage and administration on the basis of which the period is set |
|---|---|---|
| Atropine | 3 | 1 milligram (mg) of atropine sulphate per horse four times a day by eye drops |
| Indomethacin | 3 | 500 mg per animal, applied once daily for 3 days |
| Eltenac | 14 | 0.5 mg per kilogram (kg) of body by weight intravenous adm. once daily for 5 days |
| Carprofen | 15 | 0.7 mg per kg of body weight by intravenous adm. |
| Ketoprofen | 5 | 2.2 mg per kg of body weight by intravenous adm. once daily for 5 days |
| 10 | 2.2 mg per kg body weight by intramuscular adm. | |
| Diclofenac | 5 | 1 mg of diclofenac sodium per kg body weight by oral adm. once daily for 3 days |
| Dexamethasone | 5 | 0.06 mg as dexamethasone sodium phosphate per kg body weight by intravenous adm. |
| 8 | 0.05 mg per kg body weight by intramuscular adm. | |
| Naproxen | 30 | 10 mg per kg body weight by oral adm. once daily for 5 days |
| Filocoxib | 30 | 0.1 mg per kg body weight by oral adm. once daily for 5 days |
| Phenylbutazone | 10 | 8.8 mg per kg body weight by intravenous adm. |
| 10 | 4.7 mg per kg body weight by oral adm. twice daily for 5 days | |
| Flunixin | 7 | 1.1 mg per kg body weight by intravenous adm. |
| Prednisolone | 3 | 1 mg per kg body weight by oral adm. |
| Procaine | 15 | 4.8 mg per kg body weight by intramuscular adm. |
| Betamethasone | 5 | 0.06 mg per kg body weight by intravenous adm. |
| 6 | 20 mg per horse by intramuscular adm. | |
| 5 | Inhalation 4 mg per horse once daily for 5 days | |
| Meloxicam | 4 | 0.6 mg per kg body weight by intravenous adm. |
| 4 | 0.6 mg per kg body weight by oral adm. once daily for 14 days | |
| Lidocaine | 5 | 60 mg of lidocaine hydrochloride per head by subcutaneous adm. |
(Remark.)
1 The number of days of the restricted period shall be calculated from the date of use of the relevant restricted drugs.
2 The restricted period for restricted drugs not specified in this table and the restricted period for the use of restricted drugs listed in the left-hand column of the table other than in the dosage and administration listed in the right-hand column of the table shall be as directed by the Veterinary Officer.
(Notice from the President of the Japan Racing Association / No. 36, 2007)
Matters to be Instructed by Veterinary Officers in the Saddling Enclosure
( Purpose )
Art. 1 The purpose of these regulations shall be to prescribe matters required as instructions from veterinary officers to stable staffs (trainers, jockeys, trainee jockeys, assistant trainers and grooms. Hereinafter the same shall apply) in connection with the management of horses in the saddling enclosure.
( Tethering in the Saddling Enclosure )
Art. 2 When leading horses into the saddling enclosure, trainers must notify the veterinary officer of the horse's name, have the horse undergo weighing, physical inspection, identification and horseshoe inspection, and then tether the horse in a stall designated by the veterinary officer. In such cases, trainers may, with the permission of the veterinary officer, allow jockeys, trainee jockeys, assistant trainers or grooms who handle said horse to carry out tethering on their behalf.
(Instructions for Saddling, etc.)
Art. 3 Stable staffs must saddle horses that have been led into the saddling enclosure (hereinafter "led-in horses") under instructions from a veterinary officer.
2. Stable staffs may not, without the permission of the veterinary officer, saddle a horse in any location other than the saddling enclosure.
( Prohibited Acts )
Art. 4 Stable staffs may not, without the permission of the veterinary officer, take led-in horses out of the saddling enclosure.
Art. 5 Stable staffs may not give led-in horses any drugs, feed, drinking water or any other substances inside the saddling enclosure.
2. When washing a horse's mouth inside the saddling enclosure, stable staffs may only use the water provided inside the saddling enclosure.
Art. 6 Stable staffs may not, without the permission of the veterinary officer, give medication to led-in horses, or refit, or nail the horseshoes, etc.
Art. 7 Stable staffs may not bring any litter material other than that prepared by the JRA into the stalls of the saddling enclosure.
( Restriction on Entry )
Art. 8 Persons who may enter the saddling enclosure shall be limited to personnel engaged in the administration of the race in question, stable staffs of led-in horses and other persons exceptionally permitted by the executive steward.
( Other Matters )
Art. 9 Other than those prescribed herein, any matters required as instructions to stable staffs concerning the management of horses in the saddling enclosure shall be prescribed by a veterinary officer.
Supplementary Provision
This Notice shall take effect from October 1st, 2007.
(Notice from the President of the Japan Racing Association / No. 37, September 3rd, 2007)
Matters to be Instructed by Veterinary Officers in the Sample Collecting Enclosure
( Purpose )
Art. 1 The purpose of these regulations shall be to prescribe matters required as instructions from veterinary officers in connection with the management of horses in the sample collecting enclosure.
( Tethering in the Sample Collecting Enclosure )
Art. 2 Trainers of horses that are to undergo physico-chemical tests as prescribed in Paragraph 1 of Article 134 of the JRA Rules of Racing (President's Notice No. 28, 2007) must, immediately after the finishing order of the race in question is made official, tether said horse in the sample collecting enclosure (including a stable or racehorse clinic designated by a veterinary officer under the provisions of Paragraph 1 of Article 4. Hereinafter the same shall apply, with the exception of Article 6) until the collection of samples is finished. In such cases, trainers may, with the permission of the veterinary officer, allow jockeys, assistant trainers or stable employees who handle said horse to carry out tethering on their behalf.
2. The person responsible for tethering a horse in the sample collecting enclosure (hereinafter “witness”) must notify the veterinary officer of any unruly habit or other specific characteristic of said horse.
( Attendance at Sample Collection )
Art. 3 Witnesses must attend and confirm the collection of samples from horses in the sample collecting enclosure, and must check the label affixed to the sample container and then sign it as instructed by the veterinary officer.
( Instructions Concerning Sample Collection )
Art. 4 A veterinary officer may, when deeming it appropriate, collect samples in a stable or racehorse clinic designated by said veterinary officer.
2. The tethering time required for collection of samples shall be no more than 70 minutes, provided, however, that this may be extended if deemed particularly necessary by the veterinary officer.
3. Witnesses must follow instructions from the veterinary officer concerning the identification of the horse's body for sample collection, washing the horse's body, accommodation in the collection stall, leading movement, etc.
( Prohibited Acts )
Art. 5 Witnesses may not give horses any drugs, feed, or substances other than the water obtained directly from a faucet until the collection of samples is complete, provided, however, that this shall not apply when exceptionally permitted by the veterinary officer.
Art. 6 Witnesses may not bring any litter material other than that prepared by the JRA into the stalls of the sample collecting enclosure.
( Restriction on Entry )
Art. 7 Other than the witnesses, persons who may enter the sample collecting enclosure shall be limited to personnel engaged in the administration of the race in question and other persons exceptionally permitted by the executive steward.
( Other Matters )
Art. 8 Other than those prescribed herein, any matters required as instructions to stable personnel concerning the management of horses in the sample collecting enclosure shall be prescribed by a veterinary officer.
Supplementary Provision
This Notice shall take effect from October 1st, 2007.
Supplementary Provision (Notice from the President of the Japan Racing Association / No. 25, November 24th, 2017)
This Notice shall take effect from January 1st, 2018.
Supplementary Provision (Notice from the President of the Japan Racing Association / No. 12; March 23rd, 2022)
This Notice shall take effect from April 1st, 2022.
